Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/3/2025 | $108.00 | Market Perform | BMO Capital Markets |
| 9/12/2024 | $109.00 | Equal Weight | Wells Fargo |
| 8/27/2024 | $99.00 | Underweight | Barclays |
| 4/11/2024 | $106.00 → $120.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 4/8/2024 | $92.00 → $114.00 | Sell → Hold | TD Cowen |
| 1/8/2024 | $95.00 → $105.00 | Equal Weight → Underweight | Wells Fargo |
| 1/4/2024 | $88.00 | Underperform | TD Cowen |
| 10/31/2023 | $100.00 → $95.00 | Sell → Neutral | Citigroup |
NEW YORK, March 12, 2026 /PRNewswire/ -- T. Rowe Price OHA Select Private Credit Fund (the "Company" or "OCREDIT") today reported financial results and total distributions of $0.69 per share for the quarter ended December 31, 2025. As private credit remains a key driver of financing solutions within credit markets, OCREDIT closed the fourth quarter with the addition of 16 new portfolio companies across a diverse range of industries, representing portfolio net growth of nearly $210.1 million. OCREDIT's $2.9 billion investment portfolio is now comprised of exposure to 135 portfoli
The firm's active ETF lineup expands to 32 with today's addition of the T. Rowe Price Emerging Markets Equity Research ETF, which began trading todayBALTIMORE, March 12, 2026 /PRNewswire/ -- T. Rowe Price, a global investment management firm and a leader in retirement, announced today the addition of the T. Rowe Price Emerging Markets Equity Research ETF (Ticker: TEMR). The new active exchange-traded fund (ETF) expands the firm's ETF offerings into the emerging markets category. It applies a similar research approach as other offerings in T. Rowe Price's suite of structured research funds, which implement active stock selection based on the "best ideas" input of the firm's equity research an
BALTIMORE, March 11, 2026 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced February month-end assets under management of $1.80 trillion. Net outflows for February 2026 were $5.3 billion. The below table shows the firm's assets under management as of February 28, 2026, and for the prior month- and year-end by asset class and in the firm's target date retirement portfolios.As of(in billions)2/28/20261/31/202612/31/2025 Equity$ 868$ 879$ 879 Fixed income, including money market216213212 Multi-asset660646627 Alternatives595958Total a
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
4 - PRICE T ROWE GROUP INC (0001113169) (Issuer)
BMO Capital Markets initiated coverage of T. Rowe Price with a rating of Market Perform and set a new price target of $108.00
Wells Fargo initiated coverage of T. Rowe Price with a rating of Equal Weight and set a new price target of $109.00
Barclays initiated coverage of T. Rowe Price with a rating of Underweight and set a new price target of $99.00
10-K - PRICE T ROWE GROUP INC (0001113169) (Filer)
8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)
8-K - PRICE T ROWE GROUP INC (0001113169) (Filer)
BALTIMORE, Feb. 4, 2026 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW), announced its financial results for the fourth quarter and full year 2025. The earnings release can be found on the firm's website at troweprice.com/newsroom. Chair, CEO, and President Rob Sharps and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast today from 8:00 - 8:45 AM (Eastern Time). To access the webcast or to obtain dial-in instructions to ask a question, please visit investors.troweprice.com.
BALTIMORE, Oct. 31, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced its financial results for the third quarter of 2025. The earnings release can be found on the firm's website at troweprice.com/newsroom. Chair, Chief Executive Officer, and President Rob Sharps and Chief Financial Officer Jen Dardis will provide an update on business performance, review financial results, and answer questions on a webcast today from 8:00 - 8:45 AM ET. To access the webcast or to obtain dial-in instructions to ask a question, please visit investors.troweprice.com. Sup
BALTIMORE, Oct. 28, 2025 /PRNewswire/ -- T. Rowe Price Group (NASDAQ-GS: TROW), a global asset management firm and a leader in retirement, announced today that its Board of Directors has declared a quarterly dividend of $1.27 per share payable on December 30, 2025, to stockholders of record as of the close of business on December 15, 2025. ABOUT T. ROWE PRICE T. Rowe Price (NASDAQ-GS: TROW) is a leading global asset management firm entrusted with managing $1.77 trillion in client assets as of September 30, 2025, about two-thirds of which are retirement-related. Renowned for ov
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)
SC 13G/A - PRICE T ROWE GROUP INC (0001113169) (Subject)
Steven Krichbaum named successor and new head of TRPIM in 2027 BALTIMORE, Jan. 22, 2026 /PRNewswire/ -- T. Rowe Price announced today a planned leadership transition within its T. Rowe Price Investment Management division (TRPIM), as Steph Jackson, who currently serves as head of TRPIM and is a member of the Management Committee, will be retiring at the end of 2026. Jackson's tenure at T. Rowe Price has been marked by impactful leadership and a steadfast commitment to clients, associates, and community. Since joining T. Rowe Price in 2007, Jackson has held influential roles,
Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as
BALTIMORE, Nov. 13, 2025 /PRNewswire/ -- T. Rowe Price announced today the creation of a Global Strategy function to drive its strategic vision and elevate long-term planning. Andrew Reich will join the firm as head of Global Strategy on January 5, 2026. In this role, Reich will oversee the firm's corporate strategy, corporate development, mergers and acquisitions, and product development. Reich brings deep industry expertise, having most recently served as a partner and head of the Asset Management Practice for North America at McKinsey & Company. During his tenure, he helped